SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025816
Filing Date
2020-05-15
Accepted
2020-05-15 16:06:37
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pti-10q_20200331.htm 10-Q 1983414
2 EX-31.1 pti-ex311_9.htm EX-31.1 12087
3 EX-31.2 pti-ex312_6.htm EX-31.2 11996
4 EX-32.1 pti-ex321_7.htm EX-32.1 13325
  Complete submission text file 0001564590-20-025816.txt   5880116

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pti-20200331.xml EX-101.INS 1179491
6 XBRL TAXONOMY EXTENSION SCHEMA pti-20200331.xsd EX-101.SCH 36469
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pti-20200331_cal.xml EX-101.CAL 43819
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pti-20200331_def.xml EX-101.DEF 93181
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pti-20200331_lab.xml EX-101.LAB 330536
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pti-20200331_pre.xml EX-101.PRE 236496
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 20885046
SIC: 2834 Pharmaceutical Preparations